Adjusting D-dimer to Lung Disease Extent to Exclude Pulmonary Embolism in COVID-19 Patients (Co-LEAD)

Benjamin Planquette1,2,3,4, Lina Khider2,5,6, Alice Le Berre7

  • 1Innovative Therapies in Haemostasis, Université de Paris, INSERM, Paris, France.

Thrombosis and Haemostasis
|February 10, 2022
PubMed

Insights

A new algorithm (Co-LEAD) safely excludes pulmonary embolism (PE) in coronavirus disease 2019 (COVID-19) patients using adjusted D-dimer thresholds based on lung damage. This approach can reduce the need for CT pulmonary angiography (CTPA).

Area of Science:

  • Pulmonary Medicine
  • Infectious Diseases
  • Diagnostic Imaging

Background:

  • D-dimer testing is valuable for excluding pulmonary embolism (PE).
  • Its specificity is reduced in coronavirus disease 2019 (COVID-19) patients, leading to increased computed tomography pulmonary angiography (CTPA) use.
  • A need exists for improved diagnostic strategies in COVID-19 patients with suspected PE.

Purpose of the Study:

  • To develop and validate a new algorithm (Co-LEAD) to optimize D-dimer thresholds for PE exclusion in COVID-19 patients.
  • To assess the algorithm's safety and potential to reduce CTPA utilization.

Main Methods:

  • A retrospective, multicenter cohort study of 774 COVID-19 patients with suspected PE.
  • A D-dimer threshold adjusted for lung damage extent (<50% or ≥50%) was derived in a patient set (n=337).
  • The algorithm's safety and performance were validated in an independent set (n=337).

Main Results:

  • The Co-LEAD algorithm demonstrated high sensitivity (98.2% derivation, 96.7% validation) for PE exclusion.
  • Specific D-dimer thresholds (900 ng/mL or 1700 ng/mL) based on lung damage extent were established.
  • The algorithm could potentially allow 30.4% of patients to avoid CTPA, with a negative likelihood ratio of 0.06-0.08.

Conclusions:

  • The Co-LEAD algorithm provides a safe method for excluding PE in COVID-19 patients.
  • Implementation of this algorithm may significantly reduce the reliance on CTPA in this patient population.
  • Further prospective studies are recommended to confirm these findings.
Abstract

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
60
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
64
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.6K
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
162
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
43
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
54